ConductScience.org, home

Paper11645897

Delaying approval of a critical drug: safety, efficacy, economics, compassion.

Rosenberg LT. J Med Humanit, 1994. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Delaying approval of a critical drug: safety, efficacy, economics, compassion. Papers, record 11645897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11645897

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Delaying approval of a critical drug: safety, efficacy, economics, compassion.
PubMed
Journal
J Med Humanit
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2019-12-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosenberg LTLeo T

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Critical IllnessMajor topic
Drugs, InvestigationalMajor topic
Government RegulationMajor topic
Patient CareMajor topic
Public PolicyMajor topic
Social Control, FormalMajor topic
United States Food and Drug AdministrationMajor topic
Acquired Immunodeficiency Syndrome
European Union
Federal Government
Government
Human Experimentation
Humans
Infections
Military Personnel
Neoplasms
Patient Advocacy
Politics
United States

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14164249Protection against lethality of E. coli endotoxin with "O" antiserum.Ann N Y Acad Sci1966https://conductscience.org/library/papers/4164249PubMed
211646205A critique of pure reason, a passion to survive: cheating on AIDS trials.N Y Times Web1990https://conductscience.org/library/papers/11646205PubMed
33395101Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3395101PubMed
42104656Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987.MMWR Morb Mortal Wkly Rep1990https://conductscience.org/library/papers/2104656PubMed
55038951Type-specific and cross-reactive antibodies in gram-negative bacteremia.N Engl J Med1972https://conductscience.org/library/papers/5038951PubMed
63306374A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.N Engl J Med1987https://conductscience.org/library/papers/3306374PubMed
71865548Monoclonal antibodies to endotoxin. New allies against sepsis?JAMA1991https://conductscience.org/library/papers/1865548PubMed
82245602Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.Crit Care Med1990https://conductscience.org/library/papers/2245602PubMed
92888017Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.N Engl J Med1987https://conductscience.org/library/papers/2888017PubMed
106752708Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.N Engl J Med1982https://conductscience.org/library/papers/6752708PubMed
111865542A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.JAMA1991https://conductscience.org/library/papers/1865542PubMed
121988835Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.N Engl J Med1991https://conductscience.org/library/papers/1988835PubMed
131988827Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.N Engl J Med1991https://conductscience.org/library/papers/1988827PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
38784667Next generation single-domain antibodies against respiratory zoonotic RNA viruses.Front Mol Biosci2024https://conductscience.org/library/papers/38784667PubMed
22531442Marketed therapeutic antibodies compendium.MAbs2012https://conductscience.org/library/papers/22531442PubMed
20711288Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression.Indian J Psychiatry2005https://conductscience.org/library/papers/20711288PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11645897

GET https://conductscience.org/api/papers/v1/11645897/authors